Um estudo piloto de anestesia local para cirurgia de hérnia inguinal em adultos mais velhos
The purpose of this study is to collect data about local versus general anesthesia for inguinal hernia repair in Veterans aged 60 years for planning a larger, multisite randomized clinical trial. Approximately 80 participants will be enrolled and can expect to be on study for 6 months.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
The study rationale is that prior to conducting a multisite randomized trial, it is necessary to identify relevant outcomes, understand barriers to greater use of local anesthesia, test study procedures, and confirm our ability to adequately recruit and randomly assign participants. Additionally, the proposed study will provide the applicant with critical training in the design, conduct, and analysis of clinical trials. This will uniquely position the applicant to change surgical care for older adults.
More specifically, the investigators plan to demonstrate the ability to successfully randomize Veterans aged 60 years and older to local versus general anesthesia for inguinal hernia surgery, and to validate processes and instruments to measure relevant outcomes.
Although the original NIA-approved proposal involved only two arms, open hernia repair using local anesthesia and open repair using local anesthesia, the study team subsequently published a paper that showed using local anesthesia for open hernia repair may also be superior to laparoscopic or robotic hernia repair. Consequently, a third arm is added to our pilot study: laparoscopic or robotic hernia repair with general anesthesia (these surgical approaches cannot be done using local anesthesia). The rationale is that use of laparoscopic or robotic inguinal hernia surgery, while still less common than open repair, is becoming more common and no prior randomized trials have compared laparoscopic/robotic surgery versus open repair using local anesthesia.
Local or general anesthesia are the primary methods of anesthesia for inguinal hernia surgery for most surgeons (though some perform the operation under spinal or regional anesthesia, this is rare). Both approaches are used in clinical practice with acceptable known risks and complications. General anesthesia is associated with risks of hypotension, venous thromboembolism, heart attack, stroke, pulmonary dysfunction, cognitive dysfunction, allergic reaction, urinary retention, and malignant hyperthermia. The main risks of local anesthesia include allergic reaction and hypotension (when the anesthetic is improperly injected into a blood vessel).
The primary objective is to:
- demonstrate ability to successfully recruit, randomize, and retain patients aged 60 years and older for a randomized trial of local versus general anesthesia for inguinal hernia surgery, and
- establish the ability to measure relevant outcomes and test protocols and study instruments for measuring key outcomes.
The secondary objective is to generate preliminary comparisons between the study arms, to inform effect size estimates for a larger multisite trial.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Texas
-
Dallas, Texas, Estados Unidos, 75390
- University of Texas Southwestern Medical Center
-
Houston, Texas, Estados Unidos, 77030
- Baylor College of Medicine
-
-
Wisconsin
-
Madison, Wisconsin, Estados Unidos, 53705
- University of Wisconsin
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Age greater than or equal to 60 years
- Presenting to clinic with a unilateral inguinal hernia that is not incarcerated
- Considered suitable for either general or local anesthesia
- Willing to complete all study requirements, including follow-up continuing until six months after surgery
- English speaking
Exclusion Criteria:
- The hernia that the patient is being evaluated for has undergone prior repair
- Any contraindications to general anesthesia
- Allergies to local anesthesia
- Evidence of hernia incarceration or strangulation
- Active local or systemic infection that would preclude the use of mesh for hernia repair
- Need for concurrent surgical repair at the time of hernia repair
- English is not the patient's primary language
- Enrollment in other research studies
- Clinical judgement of surgeon or anesthesiology
- Current pregnancy
- Unwilling to provide consent
- Current active illegal drug use
- Current alcoholism
- Claustrophobia
- Unable to tolerate lying in supine position for greater than 30 minutes
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Open Inguinal Repair- Local anesthesia
This arm will receive local anesthesia for their open inguinal hernia repair. |
Patients in the local anesthesia arm will receive an injection of a 50:50 mix of 1% lidocaine with epinephrine and 0.25% Marcaine at the surgical site (in the skin and subcutaneous layers + beneath the external oblique aponeurosis). Patients in the local arm will also receive intravenous sedation (Propofol or Precedex) and pain medication (morphine or fentanyl) at the discretion of the attending anesthesiologist. |
|
Comparador Ativo: Inguinal Hernia Repair- General Anesthesia
This arm will receive general anesthesia for their open inguinal hernia repair or laparoscopic / robotic repair. |
General anesthesia will be administered at the discretion of the anesthesiologist and will involve a combination of inhaled and intravenous anesthesia. |
|
Sem intervenção: Observational: Standard of Care
Participants will receive anesthesia and surgery as decided by their care team. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Rates of enrollment and percentage of eligible patients enrolled
Prazo: Through study completion, estimated 2 years
|
Each week, research assistants will compile running counts of patients screened, found eligible, and enrolled. |
Through study completion, estimated 2 years
|
|
Proportion of participants completing all study visits
Prazo: Through study completion, estimated 2 years
|
Assistants will maintain counts of participants who complete each study visit. |
Through study completion, estimated 2 years
|
|
Proportion of missing data
Prazo: Through study completion, estimated 2 years
|
At each visit, every study visit will be entered into our electronic database and missing items will have a separate code number. |
Through study completion, estimated 2 years
|
|
Time to complete study evaluations and instruments
Prazo: Time from beginning to end of completing study instrument, up to 2 hours
|
Assistants will time participants while completing each study research form and will time the entire encounter. |
Time from beginning to end of completing study instrument, up to 2 hours
|
|
Participant satisfaction
Prazo: At 6 month follow up
|
A 10 point likert scale will measure participant satisfaction. Scores range from 1-10 with higher scores indicating higher satisfaction. |
At 6 month follow up
|
|
Whether Survey Instruments Can Be Eliminated due to Redundancy measured by R2 greater than 40%
Prazo: measured at 25 percent of planned enrollment and 75 percent of planned enrollment, estimated to be up to 1.5 years
|
Each survey instrument will be evaluated as the dependent variable in a separate linear regression with the scores of all other instruments used as predictors, along with demographic information. The adjusted R2 (explained variance) for each regression will be estimated. Any instrument where the R2 exceeds 40% will be eliminated based on the idea that little additional information is provided by including that instrument (i.e., the other surveys explain a substantial portion of the information contained within that instrument). |
measured at 25 percent of planned enrollment and 75 percent of planned enrollment, estimated to be up to 1.5 years
|
|
Estimate sample size for fully powered randomized trial
Prazo: Final sample size estimate will be performed after data collection for the last patient is complete, estimated up to 2 years
|
For continuous variables, means and standard deviations will be estimated. For categorical variables, estimated proportions and 95% confidence intervals. |
Final sample size estimate will be performed after data collection for the last patient is complete, estimated up to 2 years
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Carolinas Comfort Scale Score
Prazo: Measured at baseline, 48 hours after surgery, 2 weeks after surgery, 6 months after surgery
|
The Carolinas Comfort Scale measures quality of life. Possible scores range from 1-6 for each item, with higher scores indicating increased quality of life. |
Measured at baseline, 48 hours after surgery, 2 weeks after surgery, 6 months after surgery
|
|
Physical Function Score
Prazo: Measured at baseline, 48 hours after surgery, 2 weeks after surgery, 6 months after surgery
|
The patients' ability to perform their activities of daily living will be measured with the 6 item Katz index. This scale is from 0-6, with higher scores indicating more functional independence. |
Measured at baseline, 48 hours after surgery, 2 weeks after surgery, 6 months after surgery
|
|
Trail Making Test
Prazo: Measured at baseline, prior to discharge, 48 hours after discharge, 2 weeks after surgery, 6 months after surgery
|
Trail Making Test will be used to measure cognitive function. The time to complete the trail making test is measured, with those taking greater than expected time being considered deficient. |
Measured at baseline, prior to discharge, 48 hours after discharge, 2 weeks after surgery, 6 months after surgery
|
|
Montreal Cognitive Assessment
Prazo: Measured at baseline, prior to discharge, 48 hours after discharge, 2 weeks after surgery, 6 months after surgery
|
Montreal Cognitive Assessment 5 minute form to measure cognitive function. For the Montreal Cognitive Assessment, the successfully completed skills are added to achieve a final score from 0-30, with higher numbers indicating closer to normal cognitive function. |
Measured at baseline, prior to discharge, 48 hours after discharge, 2 weeks after surgery, 6 months after surgery
|
|
Participants with Delirium
Prazo: Measured at baseline, prior to discharge, 48 hours after discharge, 2 weeks after surgery, 6 months after surgery
|
The Confusion Assessment Method short form consists of 5 questions, if inattention + acute onset and/or fluctuating course + Disorganized thinking and/or Altered level of consciousness are present this test is considered positive for delirium. |
Measured at baseline, prior to discharge, 48 hours after discharge, 2 weeks after surgery, 6 months after surgery
|
|
Pain Level
Prazo: Measured at baseline, prior to discharge, 48 hours after discharge, 2 weeks after surgery, 6 months after surgery
|
10 point visual analog scale. Patients indicate on a scale of 0-10 their current level of pain. Higher numbers indicate higher pain. |
Measured at baseline, prior to discharge, 48 hours after discharge, 2 weeks after surgery, 6 months after surgery
|
|
Postoperative complications
Prazo: Up to 2 weeks
|
All complications will be recorded based on VA Surgical Quality Improvement Program definitions. |
Up to 2 weeks
|
|
Operative time
Prazo: Time between surgery start and surgery end measured. 1 day of surgery
|
The amount of time the surgery takes (minutes) |
Time between surgery start and surgery end measured. 1 day of surgery
|
|
Anesthesia time
Prazo: Time spent in operating room. 1 day of surgery
|
The amount of time in the operating room (minutes) |
Time spent in operating room. 1 day of surgery
|
|
Recovery time
Prazo: Time spent in post anesthesia care unit. 1 day of surgery
|
Time spent in the post anesthesia care unit and stepdown units. |
Time spent in post anesthesia care unit. 1 day of surgery
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Courtney Balentine, MD, MPH, University of Wisconsin, Madison
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 2023-0980
- SMPH/SURGERY/ENDOCRINE (Outro identificador: UW Madison)
- K76AG068515 (Concessão/Contrato do NIH dos EUA)
- Protocol Version 6/26/25 (Outro identificador: UW Madison)
- 2025-1446 (Outro identificador: UW Madison - UW Health site)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .